MSM (MoSaengMo)
- Manufacturer
- Handock Cosmetics Inc
- Effective date
- 2011-11-11
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:30:06
Label at a glance#
ProductMSM (MoSaengMo)
Active ingredientPROPYLENE GLYCOL
Label structure8 sections
Label contents#
Full prescribing information#
active ingredient: propylene glycol
INACTIVE INGREDIENT SECTION
inactive ingredient: Alcohol, Perfume, Water, Salicylic acid, Tocopheryl Acetate, BHT, Benzophenone-3, Niacinamide, Dipotassium Glycyrrhizate, Salvia Miltiorrhiza Root Extract, Panax Ginseng Root Extract, Carthamus Tinctorius (Safflower) Flower Extract, Angelica Gigas Root Extract, Cnidium Officinale Root Extract, Water·Propylene Glycol·Arnica Montana Flower Extract·Arctium Lappa Root Extract·Anthemis Nobilis Flower Extract·Allium Sativum (Garlic) Bulb Extract·Hedera Helix (Ivy) Leaf/Stem Extract·Pinus Sylvestris Leaf Extract·Rosmarinus Officinalis (Rosemary) Leaf Extract·Nasturtium Officinale Flower/Leaf Extract·Lamium Album Flower Extract, PYRROLIDINYL DIAMINOPYRIMIDINE OXIDE
OTC - PURPOSE SECTION
■ Inhibits steroid 5α-reductase activity
■ Accelerate the metabolism of the hair follicle
■ Scalp protection and help to produce thick and strong hair
■ Help the growth of hair root by promoting the cell division of matrix cell.
■ Increase blood circulation in scalp and nutrition to the affected tissues
■ Hair re-growth treatment with no side effects and loss prevention
■ Accelerate the metabolism of the hair follicle
■ Scalp protection and help to produce thick and strong hair
■ Help the growth of hair root by promoting the cell division of matrix cell.
■ Increase blood circulation in scalp and nutrition to the affected tissues
■ Hair re-growth treatment with no side effects and loss prevention
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
■ Apply sufficient quantity to intended part
■ Massage the scalp or knock on the scalp using a palm so that the liquid absorbs better
■ Use 2-3 times a day. If fragrance may uncomfortable, use 1 or 2 times a day.
■ Massage the scalp or knock on the scalp using a palm so that the liquid absorbs better
■ Use 2-3 times a day. If fragrance may uncomfortable, use 1 or 2 times a day.
WARNINGS SECTION
For external use only, Do not swallow
When using this product
■ Keep out of eyes, ears, and mouth. If contact occurs, rinse with plenty of cold water right away and contact a physician. If swallowing, drink plenty of water and contact a physician
When using this product
■ Keep out of eyes, ears, and mouth. If contact occurs, rinse with plenty of cold water right away and contact a physician. If swallowing, drink plenty of water and contact a physician
DOSAGE & ADMINISTRATION SECTION
■ For best results, use with MSM shampoo together
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76369-6001-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b891-f6ea-e053-dbdaa90aa703 | Drug Facts |
| 76369-6001-2 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b891-f6ea-e053-dbdaa90aa703 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76369-6001-1 | MSM (MoSaengMo) | 100 mL in 1 BOTTLE | LIQUID | 100 | 1 | |
| 76369-6001-2 | MSM (MoSaengMo) | 300 mL in 1 BOX | LIQUID | 300 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76369-6001 | MSM (MOSAENGMO) (PROPYLENE GLYCOL) LIQUID [HANDOCK COSMETICS INC] | 1 | Legacy NDC, 2 package rows | 20111114_ff2be23d-54c6-4599-9804-15e8b999b17b.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PROPYLENE GLYCOL | ACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| PROPYLENE GLYCOL | ACTIVE MOIETY | 6DC9Q167V3 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| ANGELICA GIGAS ROOT | INACTIVE INGREDIENT | 32766B2FHX | 1 | |
| ARCTIUM LAPPA ROOT | INACTIVE INGREDIENT | 597E9BI3Z3 | 1 | |
| ARNICA MONTANA FLOWER | INACTIVE INGREDIENT | OZ0E5Y15PZ | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| CHAMAEMELUM NOBILE FLOWER | INACTIVE INGREDIENT | O2T154T6OG | 1 | |
| CNIDIUM OFFICINALE ROOT | INACTIVE INGREDIENT | 8S3OZD358J | 1 | |
| DIOXYBENZONE | INACTIVE INGREDIENT | B762XZ551X | 1 | |
| GARLIC | INACTIVE INGREDIENT | V1V998DC17 | 1 | |
| GLYCYRRHIZINATE DIPOTASSIUM | INACTIVE INGREDIENT | CA2Y0FE3FX | 1 | |
| HEDERA HELIX FLOWERING TWIG | INACTIVE INGREDIENT | 3D10KUA6BM | 1 | |
| HEDERA HELIX LEAF | INACTIVE INGREDIENT | ZP9XFG71A7 | 1 | |
| LAMIUM ALBUM FLOWER | INACTIVE INGREDIENT | 62IB9494JA | 1 | |
| NIACINAMIDE | INACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| PANAX GINSENG ROOT WATER | INACTIVE INGREDIENT | P9T4K47OM0 | 1 | |
| PINE NEEDLE OIL (PINUS SYLVESTRIS) | INACTIVE INGREDIENT | 5EXL5H740Y | 1 | |
| POLYOXYL 60 HYDROGENATED CASTOR OIL | INACTIVE INGREDIENT | 02NG325BQG | 1 | |
| ROSEMARY | INACTIVE INGREDIENT | IJ67X351P9 | 1 | |
| SAFFLOWER | INACTIVE INGREDIENT | 4VBL71TY4Y | 1 | |
| SALICYLIC ACID | INACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| SALVIA MILTIORRHIZA ROOT | INACTIVE INGREDIENT | 1693AM5SBN | 1 | |
| TOCOPHEROL | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- MSM (MoSaengMo)
- PROPYLENE GLYCOL
- ALCOHOL
- WATER
- SALICYLIC ACID
- TOCOPHEROL
- BUTYLATED HYDROXYTOLUENE
- DIOXYBENZONE
- NIACINAMIDE
- GLYCYRRHIZINATE DIPOTASSIUM
- SALVIA MILTIORRHIZA ROOT
- PANAX GINSENG ROOT WATER
- SAFFLOWER
- ANGELICA GIGAS ROOT
- CNIDIUM OFFICINALE ROOT
- ARNICA MONTANA FLOWER
- ARCTIUM LAPPA ROOT
- CHAMAEMELUM NOBILE FLOWER
- GARLIC
- HEDERA HELIX LEAF
- PINE NEEDLE OIL (PINUS SYLVESTRIS)
- ROSEMARY
- LAMIUM ALBUM FLOWER
- POLYOXYL 60 HYDROGENATED CASTOR OIL
- HEDERA HELIX FLOWERING TWIG
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 76369-6001 | 76369-6001-1, 76369-6001-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| POLYOXYL 60 HYDROGENATED CASTOR OIL | PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | GEL / TOPICAL | 352 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, EXTENDED RELEASE / ORAL | 1 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAVENOUS | 2.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET / SUBLINGUAL | 0.13 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | TABLET / ORAL | 0.08 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE, LIQUID FILLED / ORAL | 0.1 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, FOR SUSPENSION / ORAL | 0.1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SPRAY / TOPICAL | 3 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / VAGINAL | 0.05 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| POLYOXYL 60 HYDROGENATED CASTOR OIL | PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | CREAM / TOPICAL | 1.9 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | GEL / TOPICAL | 25 mg | ||
| POLYOXYL 60 HYDROGENATED CASTOR OIL | PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | INJECTION / INTRAVENOUS | 20 %w/v | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION / ORAL | 14 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / RECTAL | 1 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION / INTRAVENOUS | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | LOTION / TOPICAL | 1000 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / VAGINAL | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | AEROSOL, FOAM / TOPICAL | 4 mg | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | CAPSULE, COATED / ORAL | 0.25 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / TOPICAL | 6 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SHAMPOO / TOPICAL | 0.1 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET / ORAL | 3 mg | ||
| PINE NEEDLE OIL (PINUS SYLVESTRIS) | PINE NEEDLE OIL (PINUS SYLVESTRIS) | 5EXL5H740Y | LOTION / TOPICAL | 0.25 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SWAB / TOPICAL | 0.5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 668ce835-5a1c-4454-9360-e7b74a4576b5 | ff2be23d-54c6-4599-9804-15e8b999b17b | 2011-11-11 | Warnings | 668ce835-5a1c-4454-9360-e7b74a4576b5 ff2be23d-54c6-4599-9804-15e8b999b17b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
